Kinam Park	JCR Cover Stories

• Appointments
• Research
  • Topics
  • Year
  • PLGA
• Publication
  • Research Papers
  • Cover Stories
  • Opinions
• Teaching
  • Drug Delivery
  • Polymers
• PLGA
• Home

 

• JCR 130-150, 2008-2011
  • JCR 130, 139, 2008, Minko.pdf
  • JCR 130, 201, 2008, Duncan.pdf
  • JCR 131, 1, 2008, Goto.pdf
  • JCR 132, 1, 2008, Bagatolli.pdf
  • JCR 132, 75, 2008, Golomb.pdf
  • JCR 132, 151, 2008, Sanders.pdf
  • JCR 133, 1, 2008 Kolach.pdf
  • JCR 133, 87, 2009, Golomb.pdf
  • JCR 133, 87, 2009, Kataoka.pdf
  • JCR 134,1, 2009 Yamashita.pdf
  • JCR 134, 73 2009 Discher.pdf
  • JCR 134, 157 2009 Kempen.pdf
  • JCR 135, 1 2009 Park TG.pdf
  • JCR 135, 103 2009 Fletcher.pdf
  • JCR 135, 103 2009 Fletcher 2.pdf
  • JCR 135, 185 2009 De Geest.pdf
  • JCR 136, 1 2009 Harashima.pdf
  • JCR 136, 87 2009 Shea.pdf
  • JCR 136, 171 2009 Takeuchi.pdf
  • JCR 137, 1, 2009 Kreuter.pdf
  • JCR 137, 89, 2009 Sauer.pdf
  • JCR 137, 173, 2009 Murua.pdf
  • JCR 138, 1 2009 Melot.pdf
  • JCR 138, 89 2009 Preat.pdf
  • JCR 138, 224 2009 Lange.pdf
  • JCR 139, 1 2009 Cho.pdf
  • JCR 139, 1 2009 Cho2.pdf
  • JCR 139, 87 2009 Pooga.pdf
  • JCR 139, 171, 2009 Kendall.pdf
  • JCR 140, 1, 2009 Deng.pdf
  • JCR 140, 77 2009 PTX, DTX.pdf
  • JCR 140, 185 2009 Park, Bae, Grainger.pdf
  • JCR 140, 185 2009 Szoka.pdf
  • JCR 141, 1 2009, Asai.pdf
  • JCR 141, 109 2010, Ferrara.pdf
  • JCR 141, 263 2010 Cover Nanotech.pdf
  • JCR 141, 263 2010 Daan.pdf
  • JCR 142, 1 2010 Richardson.pdf
  • JCR 142, 147 2010 PEG.pdf
  • JCR 142, 295 2010 Huang.pdf
  • JCR 143, 1 2010 Sasaki.pdf
  • JCR 143, 167 Dufe.pdf
  • JCR 143, 281 2010 Kim.pdf
  • JCR 144, 1 2010 Pack.pdf
  • JCR 144, 117 2010 Fidgor.pdf
  • JCR 144, 269 2010 Aime.pdf
  • JCR 145, 1 2010 Irache.pdf
  • JCR 145, 75 2010 Prakash.pdf
  • JCR 145, 177 2010 Renaud.pdf
  • JCR 146, 1 2010 Morishita.pdf
  • JCR 146, 163 2010 NanoDDS.pdf
  • JCR 146, 263 2010 Lin.pdf
  • JCR 147, 1 2010 Akaike.pdf
  • JCR 147, 153 2010 Kim.pdf
  • JCR 147, 313 2010 Smith.pdf
  • JCR 148, 265 1010 Yuk.pdf
  • JCR 149, 91 2011 Riganti.pdf
  • JCR 149, 207 2011 Muro.pdf
  • JCR 150, 127 2011 Bachtarzi.pdf
  • JCR 150, 237 2011 Chen.pdf
• JCR 151-200, 2012-2015
  • JCR 151, 1 2011 Kluza.pdf
  • JCR 151, 1 2012 Dugas.pdf
  • JCR 151, 219 2011 Groettrup.pdf
  • JCR 152 329 2011 Kendall.pdf
  • JCR 152, 207 2011 Varghese.pdf
  • JCR 153, 105 2011 Pooga.pdf
  • JCR 154, 1 2011 Hsiue.pdf
  • JCR 154, 109 2011 Bouwstra.pdf
  • JCR 155, 343 2011 Ibsen.pdf
  • JCR 156, 1 2011 Nielson.pdf
  • JCR 156, 117 2011 Lebleu.pdf
  • JCR 156, 275 2011 Lammers.pdf
  • JCR 157, 3 2012 Kratz.pdf
  • JCR 157, 167 2012 Boden.pdf
  • JCR 157, 315 2012 Allen.pdf
  • JCR 158, 1 2012 Schenk.pdf
  • JCR 158, 181 2012 Nicolay.pdf
  • JCR 158, 355 2012 Yeo.pdf
  • JCR 159, 1 2012 Dugas.pdf
  • JCR 159, 153 2012 Futaki.pdf
  • JCR 159, 311 2012 Byun.pdf
  • JCR 160, 1 2012 Mader.pdf
  • JCR 161, 150 2012 Moonen.pdf
  • JCR 161, 967 2012 Li.pdf
  • JCR 162, 258 2012 Guy.pdf
  • JCR 162, 475 2012 Anderson.pdf
  • JCR 162, 654 2012 Varghese.pdf
  • JCR 163, 266 2012 Gao.pdf
  • JCR 163, 404 2012 Golzio.pdf
  • JCR 164, 105 2012 Maruyama.pdf
  • JCR 165, 90 2013 Calafiore.pdf
  • JCR 165, 162 2013 Schmidt.pdf
  • JCR 165, 234 2013 Yokoyama.pdf
  • JCR 166, 86 2013 Kamps.pdf
  • JCR 166, 195 2013 Preat.pdf
  • JCR 166, 316 2013 Fahr.pdf
  • JCR 167, 108 2013 Hanes.pdf
  • JCR 167, 220 2013 Koning.pdf
  • JCR 167, 333 2013 Tsurkan.pdf
  • JCR 168, 103 2013 Buttery.pdf
  • JCR 168, 238 2013 Milligan.pdf
  • JCR 168, 341 2013 Grüll.pdf
  • JCR 169, 162 2013 Cui.pdf
  • JCR 170, 160 2013 Duffy.pdf
  • JCR 170, 306 2013 Lee.pdf
  • JCR 170, 487 2013 Decuzzi.pdf
  • JCR 171, 91 2013 Hoffmann.pdf
  • JCR 171, 258 2013 Sorg.pdf
  • JCR 172 2013 Questions on the role of the EPR effect in tumor targeting.pdf
  • JCR 172, 391 2013 Li.pdf
  • JCR 172, 1162 2013 Au.pdf
  • JCR 173, 166 2014 Karathanasis.pdf
  • JCR 174, 219 2014 Koning.pdf
  • JCR 175, 87 2014 Kim.pdf
  • JCR 176, 133 2014 Kapms.pdf
  • JCR 177, 108 2014 Porter.pdf
  • JCR 178, 126 2014 Ferrara.pdf
  • JCR 179, 76 2014 Remaut.pdf
  • JCR 180, 150 2014 Sarnes.pdf
  • JCR 181, 53 2014 Serratrice.pdf
  • JCR 182, 121, 2014 Faucheux.pdf
  • JCR 183, 178, 2014 Jansen.pdf
  • JCR 184, 79, 2014 Alblas.pdf
  • JCR 185, 139, 2014 Ki.pdf
  • JCR 186, 88, 2014 Höltke.pdf
  • JCR 187, 198, 2014 Satchi-Fainaro.pdf
  • JCR 188, 101, 2014 Burley.pdf
  • JCR 189 2014 Translation from mouse to human: Time to think in new boxes.pdf
  • JCR 189, 187 2014 Park.pdf
  • JCR 192, 325 2014 Au.pdf
  • JCR 194, 351 2014 Goepferich.pdf
  • JCR 196, 394 2014 Siegel.pdf
  • JCR 197, 219 2014 Thorne.pdf
  • JCR 198, 10 2014 Weinberg.pdf
  • JCR 199, 198 2015 Forbes.pdf
  • JCR 200, 233 2015 Rigneault.pdf
• JCR 201-268, 2015-2017
  • JCR 201, 101 2015 Prabhakarp.pdf
  • JCR 202, 118 2015 Howl.pdf
  • JCR 203, 189 2015 Cohen.pdf
  • JCR 204, 98 2015 Cui.pdf
  • JCR 206, 243 2015 Rapoport.pdf
  • JCR 207, 164 2015 Allen.pdf
  • JCR 209, 337 2015 Song.pdf
  • JCR 210, 246 2015 Mrsny.pdf
  • JCR 211, 171 2015 Lee.pdf
  • JCR 212, 113 2015 Liu.pdf
  • JCR 213, 193 2015 Ugaonkar.pdf
  • JCR 214, 134 2015 Kreuter.pdf
  • JCR 215, 129 2015 Yang.pdf
  • JCR 216, 169 2015 Schubert.pdf
  • JCR 217 352 2015 Roberts.pdf
  • JCR 218 116 2015 Burgess.pdf
  • JCR 220 568 2015 Stern.pdf
  • JCR 221 71 2015 Moghimi.pdf
  • JCR 222 2016 Exosome-based therapeutic approach for muscle regeneration.pdf
  • JCR 223 2016 Targeting prostate cancer cells en route to dissemination.pdf
  • JCR 224 2016 A hydrophilic matrix approach for controlled vaginal drug delivery.pdf
  • JCR 225 2016 Dissolving microneedle vaccine delivery system.pdf
  • JCR 226 2016 Isolated lung model for assessing drug absorption from PLGA microparticle.pdf
  • JCR 227 2016 Magnetic resonance imaging for developing intramuscular formulations.pdf
  • JCR 228 2016 Enhanced antitumor effects of hTRAIL by binding to endogenous albumin.pdf
  • JCR 229 2016 Visualization of focal permeation sites within epithelial barriers.pdf
  • JCR 230 2016 Sustained delivery of antibodies in vivo by local retention.pdf
  • JCR 232 2016 Enhanced antitumor effects of hTRAIL by binding to endogenous albumin.pdf
  • JCR 233 2016 Organotypic non-melanoma skin cancer models for use in preclinical research.pdf
  • JCR 234 2016 Pulmonary delivery of anti-ricin antibody: From the bench to the clinic.pdf
  • JCR 235 2016 Sustained efficacy of paclitaxel nanocrystals in hydrogel depot.pdf
  • JCR 236 2016 Acoustic Cluster Therapy for better treatment of solid tumors.pdf
  • JCR 237 2016 Mechanisms controlling drug release from coated pellets.pdf
  • JCR 238 2016 Maintaining protein activity during hydrogel cross-linking.pdf
  • JCR 239 2016 Hemocompatible and immune-safe library of citrem-phospholipid liquid crystalline nanoplatforms.pdf
  • JCR 241 2016 In vivo DNA delivery with NickFect peptide vectors.pdf
  • JCR 243 2016 Ultrasound and microbubble enhanced treatment of inoperable pancreatic cancer.pdf
  • JCR 244 2016 Ocular microparticle formulations for 6-month delivery of anti-VEGF.pdf
  • JCR 245 2017 The drug delivery field needs a well-diversified technology portfolio.pdf
  • JCR 246 2017 Drug delivery research for the future: Expanding the nano horizons and beyond.pdf
  • JCR 247 2017 Megakaryocytic microparticles for targeted delivery to hematopoietic stem cells.pdf
  • JCR 248 2017 Prevention of nanoparticle aggregation during freeze-drying.pdf
  • JCR 249 2017 Adipose-derived stem cells combined with neuregulin microparticles for efficient cardiac repair.pdf
  • JCR 250 2017 Attenuating the immunogenicity of PEGylated liposomes by gangliosides.pdf
  • JCR 251 2017 Intracellular enzymes of the retinal pigment epithelial cells for controlled drug delivery.pdf
  • JCR 252 2017 Rational drug loading of liposomes revisited.pdf
  • JCR 253 2017 Nanoparticle properties affecting nuclear targeting in cancer and normal cells.pdf
  • JCR 254 2017 Chitosan-gelatin-platelet gel composite scaffold for bone regeneration.pdf
  • JCR 255 2017 The lack of IVIVC for monoacyl phospholipid-based self-emulsifying drug delivery systems.pdf
  • JCR 256 2017 Moderate enhancement in tissue permeability by preclinical focused ultrasound.pdf
  • JCR 257 2017 Editorial for the 10th Biennial Meeting of the Israeli Chapter.pdf
  • JCR 258 2017 Towards a preventive treatment of Alzheimer’s disease with multi-functional liposomes.pdf
  • JCR 260 2017 Real-time monitoring of antibody microdistribution during photoimmunotherapy.pdf
  • JCR 261 2017 Insight into brain-targeted drug delivery via LAT1-utilizing prodrugs.pdf
  • JCR 262 2017 Enhanced intrapericardial drug delivery by PLGA nanoparticles.pdf
  • JCR 264 2017 Zebrafish as a screening tool for nanoparticles.pdf
  • JCR 266 2017 Tolerance levels of PLGA microspheres in the eyes.pdf
  • JCR 267 2017 Editorial.pdf
  • JCR 268 2017 Mechanistic understanding of ragweed pollen for oral vaccine delivery.pdf
• JCR 269-300, 2017-2019
  • Editorial 269 2018 Transparency and openness.pdf
  • JCR 269 2018 Efficient therapy of Pompe disease by an acid α-glucosidase conjugate.pdf
  • JCR 270 2018 Absorption of orally administered ultrafine drug particles.pdf
  • JCR 271 2018 Treating resistant tumors using HER3-targeted nanobioligics.pdf
  • JCR 272 2018 Size- and site-dependent distribution of therapeutic proteins into thoracic lymph.pdf
  • JCR 273 2018 In utero gele delivery to spinal cord motor neurons.pdf
  • JCR 274 2018 Prevention of intimal hyperplasia by immobilized all-trans retinoic acid.pdf
  • JCR 275 2018 Enhanced immune responses by co-adsorption of liposomal adjuvant formulations to the aluminum-antigen complex.pdf
  • JCR 276 2018 Microchamber arrasy for controlled NIR laser meciated drug delivery to single cells.pdf
  • JCR 277 2018 Implants attenuating vaginal T lymphocyte activation and inflammation.pdf
  • JCR 278 2018 Functional recovery in spinal cord injury using mesenchymal stem cells.pdf
  • JCR 279 2018 3D mesoscopic fluorescence tomography for photoimmunotherapy monitoring in vivo.pdf
  • JCR 280 2018 Enhanced bacterial cancer therapy with hydroxychloroqunine liposomes.pdf
  • JCR 281 2018 Combined therapy of imatinib and an anti-CTLA4 immune-checkpoint inhibitor.pdf
  • JCR 283 2018 Thermo-responsive polypeptides and micromechanical machines for sustained delivery to the posterior eye.pdf
  • JCR 284 2018 Enhanced treatment of lung cancer by metronomic therapy with oral pemetrexed.pdf
  • JCR 285 2018 Triggered delivery of sequestered siRNA to the heart.pdf
  • JCR 286 2018 Quantitative non-invasive imaging of target engagement in small animals.pdf
  • JCR 287 2018 Impact of anti-PEG antibodies on PEGylated nanoparticles fate in vivo.pdf
  • JCR 288 2018 New biomedical polymer targeting E-selectin to reduce atherosclerosis.pdf
  • JCR 289 2018 Multi-functional peptide-modified liposomes for treatment of glioma.pdf
  • JCR 290 2018 Inherent antimicrobial activity by bacteria-derived vesicles.pdf
  • JCR 291 2018 Drug transport-based therapeutic resistance in breast cancer liver metastases.pdf
  • JCR 292 2018 Different phase behaviors of enzalutamide amorphous solid dispersion.pdf
  • JCR 293 2018 Core-shell polymer particles as flexible platform for vaccination.pdf
  • JCR 294 2018 Probing the mechanism of drug release from liposomes.pdf
  • JCR 295 2019 Optimal nanoparticle design for effective transport through the blood-brain barrier.pdf
  • JCR 296 2019 Albumin-binding Auristatin prodrugs for long-term tumor regressions.pdf
  • JCR 297 2019 PKPD model for liposomal chemophototherapy.pdf
  • JCR 298 2019 Transcending nanomedicine to the next level- Are we there yet.pdf
  • JCR 299 2019 Pharmacokinetic studies for cochlear drug delivery.pdf
• JCR Covers
  • 245.pdf
  • 246.pdf
  • 247.pdf
  • 248.pdf
  • 249.pdf
  • 250.pdf
  • 251.pdf
  • 252.pdf
  • 253.pdf
  • 254.pdf
  • 256.pdf
  • 257.pdf
  • 258.PDF
  • 259.pdf
  • 260.pdf
  • 261.pdf
  • 262.pdf
  • 264.pdf
  • 265.pdf
  • 266.pdf
  • 267.pdf
  • 268.pdf
  • 269.pdf
  • 270.pdf
  • 271.pdf
  • 272.pdf
  • 273.pdf
  • 274.pdf
  • 275.pdf
  • 276.pdf
  • 277.pdf
  • 278.pdf
  • 279.PDF
  • 280.pdf
  • 281.pdf
  • 282.PDF
  • 283.pdf
  • 284.pdf
  • 285.pdf
  • 286.pdf
  • 287.pdf
  • 288.pdf
  • 289.pdf
  • 290.pdf
  • 291.pdf
  • 292.pdf
  • 293.pdf
  • 294.pdf
  • 295.pdf
  • 296.pdf
  • 297.pdf
  • 298.pdf
  • 299.pdf
  • 300.pdf
  • 301.pdf
  • 302.pdf
  • 305.pdf
  • 306.pdf
  • 307.pdf
  • 308.pdf
• 1. Procedure of obtaining permission for using figures and tables.pdf
• 1. Purchase of JCR Issues.pdf
• 1. To be a JCR Reviewer.pdf
• Editorial 2019 ZZ.pdf
• JCR 300 2019, Collective progress in drug delivery.pdf
• JCR 301 2019, Bioink-guided spatio-temporal gene delivery for tissue engineering.pdf
• JCR 302 2019, What do we do next.pdf
• JCR 305 2019, The beginning of the end of the nanomedicine hype.pdf
• JCR 306 2019, Automatic antidote delivery device for opioid overdose.pdf
• JCR 307 2019, Shape-dependent bioavailability of lovastatin nanocrystals.pdf
• JCR 308 2019, Science the endless frontier.pdf
• JCR 309 2019, NCI Centers of Cancer Nanotechnology Excellence (CCNEs)- A full story to set the record straight.pdf
• JCR 317 2020, JCR is attuned for the 2020s.pdf